Press Releases about Merck & Co
![](https://mms.businesswire.com/media/20230110005333/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20230105005070/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20230103005167/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
From Merck & Co., Inc.
Via Business Wire
![](https://www.marketbeat.com/logos/articles/small_stock-image_54728615_S.jpg)
![](https://mms.businesswire.com/media/20221222005094/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
From Merck & Co., Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20221222005122/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20221221005090/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20221220005198/en/828587/5/Seagen_Logo_RGB.jpg)
![](https://mms.businesswire.com/media/20221215005293/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://mms.businesswire.com/media/20221212005250/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck Begins Tender Offer to Acquire Imago BioSciences, Inc.
December 12, 2022
From Merck & Co., Inc.
Via Business Wire
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
From Brodsky & Smith LLC
Via GlobeNewswire
![](https://mms.businesswire.com/media/20221201005292/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://mms.businesswire.com/media/20221129005797/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck Announces First-Quarter 2023 Dividend
November 29, 2022
From Merck & Co., Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20221122005263/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://spotlightgrowth.com/wp-content/uploads/2022/11/Imago-BioSciences-NASDAQ-IMGO-Acquired-by-Merck-NYSE-MRK-Bone-Marrow-Disease-Spotlight-Growth.jpg)
![](https://mms.businesswire.com/media/20221121005027/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck to Present at the 5th Annual Evercore ISI HealthCONx Conference
November 21, 2022
From Merck & Co., Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20221121005295/en/1643500/5/Imago_Main_Logo.jpg)
![](https://www.marketbeat.com/logos/articles/small_stock-image_225227766_S.jpg)
Can AbbVie Grow Revenue When Humira Biosimilars Hit The Market?
November 16, 2022
Via MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://mms.businesswire.com/media/20221114005261/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Rising Incidence of Pancreatic Cancer Driving Demand for Advanced Treatment Therapies
November 07, 2022
Exposures
COVID-19
![](https://mms.businesswire.com/media/20221107005158/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
![](https://www.marketbeat.com/logos/articles/small_stock-image_90672118_S.jpg)
Can Big Data Make Patient Care More Personalized And Effective?
October 28, 2022
Via TheNewswire.com
![](https://pressreach.com/wp-content/uploads/2022/10/Merck-Stock-1.jpg)
Merck Stock Price Rose as the Company Raised Its Full-Year Outlook Due to the Success of Keytruda
October 27, 2022
Via PressReach
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://pressreach.com/wp-content/uploads/2022/10/Merck-Stock-1.jpg)
Merck Beats Expectations for the Third Quarter as Sales of the COVID-19 Tablet Are Partially Offset by Keytruda
October 27, 2022
Via PressReach
Exposures
COVID-19
![](https://mms.businesswire.com/media/20221027005289/en/1106824/5/Merck_Logo_Horizontal_Teal%26Grey_RGB.jpg)
Merck Announces Third-Quarter 2022 Financial Results
October 27, 2022
From Merck & Co., Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.